The CIFLOTEX Study is a clinical trial to evaluate investigational medication for infants, children, and adults with Swimmer’s Ear.
Participants may qualify for this study if they are:
- Are 6 months of age or older
- Have been diagnosed with Acute Otitis Externa (AOE), Swimmer’s Ear, for less than 3 weeks
All study-related visits, tests, and drugs will be provided at no cost. In addition, reimbursement for study-related travel may be available.
Throughout the study, patient or caregiver should record ear pain severity twice a day (morning and evening, prior to take study medication) in a diary using a proper pain scale according to
patient’s age until the end of study.
The duration of the study is determined by the time it take for ear pain to subside. This will be measured in the number of days between the first dose of study medication and the time when the ear pain in the affected ear has ended. This time will be calculated on the basis of the patient diary entries using a proper pain scale according to patient’s age. During this time, all study visits and study medication will be provided to the patient at no cost.